Free guidePDF · 15 pages · 15-minute read

The Electronic Lab Notebook (ELN) Guide for Life Science Research Labs

A free 15-page LabLynx guide to electronic lab notebooks for life science research, from reproducible protocols and audit trails to GLP, FDA and HIPAA requirements and a pilot-first rollout.

By Brandon Holland, Marketing & Operations Digital Solutions ArchitectPublished April 2025

The Electronic Lab Notebook (ELN) Guide for Life Science Research Labs, a free guide from LabLynx

Get your free copy

PDF
15 pages
Instant download

"*" indicates required fields

We also email you the link.

In life science research, an electronic lab notebook (ELN) is one structured, secure and shared record of a lab's experiments, replacing paper notebooks, disconnected spreadsheets and siloed files. Templates, version control, audit trails and role-based access keep complex work reproducible and ready for publication, patenting or regulatory review. This LabLynx guide shows what an ELN changes for life science labs and how to adopt one.

What you will learn

Why life science labs need an ELN. Reproducibility, collaboration and GLP, FDA 21 CFR Part 11 and HIPAA compliance, from discovery to regulatory review.
The features that matter at the bench. Templates for ELISA, PCR and animal dosing, role-based access, audit trails, image capture and search.
Five documentation problems an ELN solves. From missing reagent IDs and lost notebooks to authorship disputes and IRB reviews.
A seven-step roadmap to adoption. From assessing your workflow and piloting one study to keeping the ELN current.

What is inside the guide

From why life science labs are leaving paper behind to a seven-step roadmap for adoption: here is what the guide covers.

The role of ELNs in life science research
Genetics, molecular biology, pharmacology and clinical research produce complex, iterative data, yet many labs still keep it in paper notebooks or siloed documents. See why accuracy, reproducibility and compliance are requirements here, and how structured entry fields, version control and built-in validation keep records complete and traceable, from a gene expression protocol to clinical trial endpoints.
Go deeper: How ELNs are advancing research across industries
Collaboration, compliance and institutional readiness
Life science projects split molecular analysis, sample preparation, animal models and clinical trial documentation across teams, sites and institutions. An ELN keeps that work in one place and embeds electronic signatures, audit trails and controlled access for labs under FDA, GLP/GCP or HIPAA oversight. It also brings the consistency that grant reporting, institutional audits and intellectual property protection depend on.
Go deeper: The NIH data management and sharing policy
Templates for every experiment type
Multi-step assays, long-term cell cultures and randomized clinical studies are hard to document consistently, especially with large or rotating teams. Customizable templates, such as ELISA or PCR result logs, animal study dosing schedules and clinical sample processing records, guide technicians and principal investigators through the same critical fields.
Permissions, version control and audit trails
Sensitive work such as drug compound data, human subject records and clinical trial data should be open only to people with clearance, with editing rights set by role. Version control and audit trails make every protocol update or experimental deviation time-stamped and attributable, which makes the procedural change behind an outlier result easy to find and gives reassurance during GLP or FDA inspections.
Go deeper: Good Laboratory Practice (GLP) compliance
Images, search and real-time sharing
Fluorescence microscopy images, gel electrophoresis results, western blot scans and instrument spreadsheets belong beside the notes they explain, in a single source of truth. Metadata tags such as GMP, validated or preclinical make past experiments quick to find for manuscripts, quality assurance and grant reports, while shared folders, comment threads and notifications keep teams aligned across institutions.
Go deeper: What a signed record should hold
Real-world challenges solved by ELNs
Five problems recur in life science labs: details such as reagent IDs, timepoints and adverse event notes go unrecorded, one lost notebook takes months or years of findings with it, and work with hospitals, CROs and pharma partners slows down on paper. Contributions become hard to credit, and FDA 21 CFR Part 11, HIPAA, GLP and IRB requirements become harder to prove. For each one, the guide shows how an ELN helps and what changes in practice.
Go deeper: 21 CFR Part 11 compliance in the lab
Assess your workflow and define your requirements
A lab is ready when researchers struggle to find prior protocols, data leaves with departing staff, or experiments are recorded inconsistently. Map how technicians, PIs, analysts and QA staff work, then list what the lab cannot compromise on, such as clinical trial audit trails, protocol templates, multimedia for assay images, HIPAA-compliant storage or integration with a LIMS or inventory tools.
Go deeper: Migrating from paper lab notebooks to an ELN
Buy-in, a pilot study and a plan that lasts
Engage researchers, technicians, QA and regulatory teams early, and in an academic medical center or biotech firm bring in IT, compliance and leadership as well. Pilot one representative workflow, such as a routine cell culture assay, a GLP-compliant animal study or an ongoing clinical sample analysis, then train with short sessions and peer champions. Set measurable goals, and name a point person to maintain templates and user access.

Get the free guide

Key takeaways

In life science, reproducibility and compliance are required. Complex, iterative data from genetics, molecular biology, pharmacology and clinical studies has to be documented, stored securely and shared, ready for publication, patenting or regulatory review.
Structure protects the science. Templates with fields for reagent IDs, timepoints, instrument settings and adverse event notes keep long, multi-step experiments complete and comparable.
Every change should be attributable. Time-stamped entries tied to a user give a full audit trail for peer review, authorship and GLP or FDA inspections.
Access should follow the role. Role-based permissions protect clinical trial, patient and drug compound data, while partners such as hospitals and CROs see only what they need.
Pilot before you scale. Start with one representative workflow, such as a cell culture assay or a GLP-compliant animal study, then train, measure and keep someone in charge of the ELN.

The seven-step roadmap

Assess your current workflow. Find where experimental data is recorded, stored and shared, and where that falls short: protocols no one can find, data lost when people leave, experiments recorded differently.
Define your ELN requirements. For example clinical trial audit trails, customizable protocol templates, multimedia for assay images and instrument readouts, HIPAA-compliant storage or integration with a LIMS.
Get buy-in from your team and institution. Involve researchers, technicians, QA and regulatory staff early, and IT, compliance and leadership in an academic medical center or biotech firm.
Start with a pilot project. Document one representative workflow fully, such as a routine cell culture assay or a GLP-compliant animal study, and refine templates and search from it.
Create a simple training plan. Short sessions, walkthrough videos or step-by-step guides on creating entries, uploading data and collaborating, with peer champions to help.
Establish goals and measure progress. Less time on documentation, better audit readiness and fewer protocol adherence errors, with early wins such as the first regulatory-ready protocol.
Build for long-term sustainability. Name a point person for templates, user access and onboarding, and review ELN use with the team at regular check-ins.

This page is the summary. The full guide has the detail, all 15 pages of it.

PDF · 15 pages · 15-minute read. Free.

Get the free guide

Who it is for

Principal investigators and lab directors

who need complete, audit-ready datasets and a clear record of who contributed what to each study.

Research scientists and technicians

who run multi-step assays, cell cultures and animal studies and want templates that capture every critical detail.

QA, compliance and regulatory staff

who prepare for GLP or FDA inspections and IRB reviews, and need audit trails, electronic signatures and controlled access.

Written for Biomedical, genetics, molecular biology, immunology, pharmacology and clinical research labs, in biotech firms, pharma research groups and academic medical centers.

About the author

Brandon Holland

Marketing & Operations Digital Solutions Architect

Brandon Holland is the Marketing & Operations Digital Solutions Architect at LabLynx, where he writes guides and articles for lab professionals. He wrote this guide to show how electronic lab notebooks are changing life science research, and how a lab can implement one to support long-term success.

LabLynx has built laboratory information management software for more than 25 years.

Put it into practiceGet started with LabLynxWhen your requirements are clear, from clinical trial audit trails and protocol templates to HIPAA-compliant storage, and it is time to evaluate vendors, talk to LabLynx about how your lab documents its research today. Ask for personalized information, a demo or pricing.Talk to a LabLynx specialist

About the guide

Answers from the guide, in brief.

Get the free guide

Why does the guide say life science labs need an ELN?

Because accuracy, reproducibility and compliance are required, not just preferred, and the data is complex, iterative and time-sensitive. Paper notebooks and siloed documents get in the way of collaboration, slow review cycles and raise the risk of falling short of GLP, FDA 21 CFR Part 11 or HIPAA. An ELN brings structured documentation, secure storage and shared work, so researchers are ready for publication, patenting or regulatory review, and institutions for grant reporting and audits.

Which ELN features does the guide say matter most in life science research?

Six. Customizable templates, such as ELISA or PCR result logs, animal study dosing schedules and clinical sample processing records; role-based permissions that protect clinical trial and patient data; version control and audit trails; multimedia support for microscopy images, gels and western blot scans; searchable archives with metadata tags such as GMP, validated or preclinical; and collaboration tools, from shared folders by project, trial phase or sample type to comment threads and review notifications.

How does the guide say an ELN protects reproducibility?

Through structure and history. Templates make sure fields such as reagent IDs, timepoints, instrument settings and adverse event notes are never missed, and walk researchers through setup, data collection and observations the same way every time, so experiments can be compared across conditions or over time. Every change is time-stamped and tied to a user, which makes it simpler to find the procedural change behind an outlier result.

Which regulations and reviews does the guide help a life science lab prepare for?

FDA 21 CFR Part 11, GLP and GCP, HIPAA, and IRB or ethics committee documentation, as well as the requirements of funding bodies. The guide names electronic signatures, locked entries, role-based access and complete audit logs as the features that let documentation meet oversight requirements. In practice, standardized experiment logs support GLP and GxP compliance, IRB documentation stays ready for review, and built-in safeguards reduce the time spent on compliance administration.

How does the guide recommend sharing work with hospitals, CROs and other partners?

Life science research often spans research institutions, hospitals, CROs and biotech or pharma companies, and paper makes that work clunky and error-prone. The guide recommends real-time collaboration in the ELN: partners review protocols, comment and contribute data at the same time from different locations, while controlled access means each sees only what they need. Every entry, edit and comment is time-stamped and tied to a user, so contributions can be credited and accounted for.

Where does the guide suggest a life science lab start?

With its current workflow: where experimental data is recorded, how it is stored and shared, and how technicians, PIs, analysts and QA staff work differently. Then define what the lab cannot compromise on, win buy-in early, and pilot one representative workflow, such as a routine cell culture assay, a GLP-compliant animal study or an ongoing clinical sample analysis, before the full rollout. Train simply, set measurable goals and name a point person to keep the ELN current.

Free guide